Merck Keytruda in combination with chemotherapy gets European nod as treatment for breast cancer Ruchika Sharma24 Oct 2021 9:30 AM ISTKenilworth: Merck, known as MSD outside the United States and Canada, has recently announced that the European Commission (EC) has approved KEYTRUDA,...
Statins use associated with better survival in patients with triple-negative breast cancer, study finds Hina Zahid10 Aug 2021 10:45 AM ISTTexas: Initiation of statin therapy in the 12 months after a breast cancer diagnosis is associated with better survival rates in triple-negative...
Gilead Sciences application for breast cancer therapy gets EMA validation Ruchika Sharma28 March 2021 11:00 AM ISTFoster City: Gilead Sciences has recently announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application...
Tata Memorial Hospital conducts pilot study for triple negative breast cancer Pooja Bhatia Bhatia4 March 2016 10:58 AM ISTMumbai : Tata Memorial Hospital has initiated a pilot study to provide cheaper drugs for patients suffering from triple negative breast cancer.The...
